DS-1594a·HCl and DS-1594a·succinate resulted in complete remission (CR) in in vivo xenograft models of MLL1-r AML/ALL and NPM1c AML, suggesting that strong antitumor medicinal effects can be expected in clinical studies. Here, KMT2A is linked to acute myeloid leukemia.